Objectives We aimed to determine whether changes in acute severe colitis (ASC) management
have translated to improved outcomes and to develop a simple model predicting steroid …

Background Although hepatitis C virus (HCV) infection is curable, treatment of difficult to
access populations (DTAP) presents unique challenges. Project ECHO (PE) (Extension for …

Acute severe ulcerative colitis [ASUC] remains a common medical emergency, with 25% of
patients with ulcerative colitis experiencing at least one event in their disease course. …

BACKGROUND There is paucity of data on outcomes of acute severe ulcerative colitis (ASUC)
in older adults (≥ 60 years of age). AIM To assess steroid non-response rates during the …

Background Therapeutic drug monitoring (TDM) of infliximab (IFX) levels in inflammatory
bowel disease (IBD) patients can help to guide dose adjustments or changes to therapy for …

Objective: Sorafenib is an oral multikinase inhibitor that improves survival in advanced
hepatocellular carcinoma (HCC). In the absence of alternative therapies, sorafenib is often …

Viral hepatitis contributes to significant morbidity and mortality worldwide. While acute infection
may be self‐limiting, unrecognised chronic infection and under‐utilisation of guideline‐…

BACKGROUND Colonoscopy remains the gold standard for detection of colonic disease.
An optimal evaluation depends on adequate bowel cleansing. Patients with inflammatory …

Objectives Systemic inflammation is increasingly being recognised as a possible mechanism
for acute arterial thrombotic events, including acute coronary syndrome (ACS). Despite this…

AIM To assess the impact of underlying liver disease etiology on the presenting features and
outcomes in a large cohort of patients with hepatocellular carcinoma (HCC). METHODS A …